ArticleMedical oncology (Northwood, London, England)2015

MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.

Chong-Chong Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.